Startups
Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients. The company is focused on the development of novel prodrugs of treprostinil to treat patients with PAH using a once-daily transdermal patch.
Overview
Location
United States, California, Sunnyvale
Employees
1-10
Total raised
$23M
FAQ about Corsair Pharma
How much funding has Corsair Pharma raised?
Corsair Pharma has raised $23M in total across 1 funding round.
Is Corsair Pharma still active?
Corsair Pharma is probably closed: its latest activity on Parsers VC dates from Sep 21, 2023.